Stocks / AHCO vs CSTL

AdaptHealth Corp. (AHCO) vs Castle Biosciences, Inc. (CSTL)

AdaptHealth Corp. and Castle Biosciences, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

AHCO is the larger company ($1.4B vs $0.6B). On the fundamentals, CSTL grows revenue faster (40.6% vs 25.2%); AHCO earns a higher net margin (-2.2% vs -7.0%); AHCO has the stronger return on equity (-4.7% vs -5.1%). Over the last five years, AHCO returned -63.6% vs -71.4%. On the filings, AHCO carries fewer potential red flags (1 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AHCO vs CSTL, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 AdaptHealth Corp. (AHCO)Castle Biosciences, Inc. (CSTL)
Market cap$1.4B$0.6B
Revenue (latest FY)$3.24B$344.23M
Net income (latest FY)$-70.79M$-24.16M
Revenue growth (5y CAGR)25.2%40.6%
Net margin-2.2%-7.0%
Return on equity-4.7%-5.1%
P/E ratio
Dividend yield
Profitable years (of last 10)42
Positive free cash flowYesYes

Performance — AHCO vs CSTL

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 AdaptHealth Corp. (AHCO)Castle Biosciences, Inc. (CSTL)
1-year return5.7%2.6%
3-year return-18.1%52.7%
5-year return-63.6%-71.4%
10-year return
52-week range$8.06–$13.43$14.59–$44.28

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AHCO vs CSTL breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AHCO's full financials →   Open CSTL's full financials →

More comparisons

Frequently asked questions

Which is bigger, AHCO or CSTL?

AdaptHealth Corp. is larger by market capitalization — $1.4B versus $0.6B.

Which grows faster, AHCO or CSTL?

Over the last five fiscal years, Castle Biosciences, Inc. grew revenue faster — 40.6%/yr versus 25.2%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AHCO fundamentals → · CSTL fundamentals → · All 1,500+ companies → · Free screener →